- Home
- CG vs ICLR Comparison
CG vs ICLR Comparison
Compare CG & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CG
- ICLR
- Stock Information
- Founded
- CG 1987
- ICLR 1990
- Country
- CG United States
- ICLR Ireland
- Employees
- CG N/A
- ICLR N/A
- Industry
- CG Investment Managers
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- CG Finance
- ICLR Health Care
- Exchange
- CG Nasdaq
- ICLR Nasdaq
- Market Cap
- CG 14.0B
- ICLR 11.4B
- IPO Year
- CG 2012
- ICLR 1998
- Fundamental
- Price
- CG $46.86
- ICLR $146.48
- Analyst Decision
- CG Hold
- ICLR Buy
- Analyst Count
- CG 15
- ICLR 12
- Target Price
- CG $48.54
- ICLR $204.18
- AVG Volume (30 Days)
- CG 2.0M
- ICLR 1.1M
- Earning Date
- CG 08-04-2025
- ICLR 07-23-2025
- Dividend Yield
- CG 2.99%
- ICLR N/A
- EPS Growth
- CG N/A
- ICLR 11.53
- EPS
- CG 2.94
- ICLR 9.19
- Revenue
- CG $5,038,700,000.00
- ICLR $8,192,621,999.00
- Revenue This Year
- CG N/A
- ICLR N/A
- Revenue Next Year
- CG $20.60
- ICLR $2.10
- P/E Ratio
- CG $15.99
- ICLR $15.62
- Revenue Growth
- CG 127.13
- ICLR N/A
- 52 Week Low
- CG $33.02
- ICLR $125.10
- 52 Week High
- CG $57.50
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- CG 57.21
- ICLR 58.35
- Support Level
- CG $45.68
- ICLR $140.20
- Resistance Level
- CG $47.89
- ICLR $147.26
- Average True Range (ATR)
- CG 1.16
- ICLR 5.06
- MACD
- CG -0.11
- ICLR 1.39
- Stochastic Oscillator
- CG 71.11
- ICLR 85.25
About CG The Carlyle Group Inc.
The Carlyle Group is one of the world's largest alternative-asset managers, with $447.4 billion in total AUM, including $313.6 billion in fee-earning AUM, at the end of September 2024. The company has three core business segments: private equity, which includes private equity, real estate, infrastructure, and natural resources funds (accounting for 33% of fee-earning AUM and 57% of base management fees during 2023), global credit (51% and 27%) and investment solutions (16% and 16%). The firm primarily serves institutional investors and high-net-worth individuals. Carlyle operates through 29 offices across five continents, serving more than 2,900 active carry fund investors from 88 countries.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.